Feed 4063.T
40

Shin-Etsu Chemical Co., Ltd. 4063.T JPX · Basic materials · Japan

¥5,481.00 -0.98% -¥54.00

Summary

71 / 100 · Bulios Score

What speaks for it

  • Out of every 100 JPY of revenue, 19 JPY is left as net profit.
  • It holds more cash than debt: ¥1.75T against ¥401.6B.
  • It earns 9.1 JPY a year on every 100 JPY of invested capital.
  • It bought back its own shares for ¥500.0B in the last fiscal year, 5.0% of its market value.

What to watch

  • Revenue fell by 2.9% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today ¥5,481

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 20.0 6.3% higher
5-year average P/E 18.8
P/E today 20.0
Chemicals industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 20.0 JPY for 1 JPY of yearly profit. Over the last five years it was 18.8 JPY on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 11% a year over 5 years. Over the last 3 years it fell by 2.9% a year. For the next fiscal year analysts expect revenue to grow by 10%.

Growth in detail

Does it make money?

Very well

Where 100 JPY of revenue goes

Net profit, industry median (Chemicals) 4.8 JPY

Out of every 100 JPY of revenue, 19 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
1.41%
Paid out of profit
28%

You receive ¥78.00 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy